Add this topic to your myFT Digest for news straight to your inbox
Brussels alleges Israeli group agreed not to market generic version of sleep aid
Book profits – and dividends – make good reading, says Kevin Goldstein-Jackson
The new chief executive is well qualified to help sort out long-term strategy
Valeant has proved it is disciplined even when the stakes are high
What the doctor ordered for Cephalon shareholders
International Edition